Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

389 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Designing Adjuvant Formulations to Promote Immunogenicity and Protective Efficacy of Leptospira Immunoglobulin-Like Protein A Subunit Vaccine.
Techawiwattanaboon T, Courant T, Brunner L, Sathean-Anan-Kun S, Krangvichian P, Iadsee N, Nakornpakdee Y, Sangjun N, Komanee P, Collin N, Ruxrungtham K, Patarakul K. Techawiwattanaboon T, et al. Among authors: ruxrungtham k. Front Cell Infect Microbiol. 2022 Jun 16;12:918629. doi: 10.3389/fcimb.2022.918629. eCollection 2022. Front Cell Infect Microbiol. 2022. PMID: 35782116 Free PMC article.
DNA vaccine candidate encoding SARS-CoV-2 spike proteins elicited potent humoral and Th1 cell-mediated immune responses in mice.
Prompetchara E, Ketloy C, Tharakhet K, Kaewpang P, Buranapraditkun S, Techawiwattanaboon T, Sathean-Anan-Kun S, Pitakpolrat P, Watcharaplueksadee S, Phumiamorn S, Wijagkanalan W, Patarakul K, Palaga T, Ruxrungtham K. Prompetchara E, et al. Among authors: ruxrungtham k. PLoS One. 2021 Mar 22;16(3):e0248007. doi: 10.1371/journal.pone.0248007. eCollection 2021. PLoS One. 2021. PMID: 33750975 Free PMC article.
Immunogenicity Studies of Plant-Produced SARS-CoV-2 Receptor Binding Domain-Based Subunit Vaccine Candidate with Different Adjuvant Formulations.
Siriwattananon K, Manopwisedjaroen S, Shanmugaraj B, Prompetchara E, Ketloy C, Buranapraditkun S, Tharakhet K, Kaewpang P, Ruxrungtham K, Thitithanyanont A, Phoolcharoen W. Siriwattananon K, et al. Among authors: ruxrungtham k. Vaccines (Basel). 2021 Jul 5;9(7):744. doi: 10.3390/vaccines9070744. Vaccines (Basel). 2021. PMID: 34358160 Free PMC article.
DNA Vaccine Administered by Cationic Lipoplexes or by In Vivo Electroporation Induces Comparable Antibody Responses against SARS-CoV-2 in Mice.
Peletta A, Prompetchara E, Tharakhet K, Kaewpang P, Buranapraditkun S, Techawiwattanaboon T, Jbilou T, Krangvichian P, Sirivichayakul S, Manopwisedjaroen S, Thitithanyanont A, Patarakul K, Ruxrungtham K, Ketloy C, Borchard G. Peletta A, et al. Among authors: ruxrungtham k. Vaccines (Basel). 2021 Aug 6;9(8):874. doi: 10.3390/vaccines9080874. Vaccines (Basel). 2021. PMID: 34451998 Free PMC article.
Safety and immunogenicity of a prefusion non-stabilized spike protein mRNA COVID-19 vaccine: a phase I trial.
Gatechompol S, Kittanamongkolchai W, Ketloy C, Prompetchara E, Thitithanyanont A, Jongkaewwattana A, Buranapraditkun S, Alameh MG, Ubolyam S, Sophonphan J, Apornpong T, Kerr S, Kamarulzaman A, Siwamogsatham S, Kroon E, Puthanakit T, Patarakul K, Palaga T, Wijagkanalan W, Carpenter A, Hong L, Weissman D, Ruxrungtham K; ChulaVAC-001 study team. Gatechompol S, et al. Among authors: ruxrungtham k. Nat Microbiol. 2022 Dec;7(12):1987-1995. doi: 10.1038/s41564-022-01271-0. Epub 2022 Nov 14. Nat Microbiol. 2022. PMID: 36376393 Clinical Trial.
Strategies to improve the immunogenicity of prM+E dengue virus type-2 DNA vaccine.
Ketloy C, Keelapang P, Prompetchara E, Suphatrakul A, Puttikhunt C, Kasinrerk W, Konishi E, Sittisombut N, Ruxrungtham K. Ketloy C, et al. Among authors: ruxrungtham k. Asian Pac J Allergy Immunol. 2017 Mar;35(1):11-19. doi: 10.12932/AP0728. Asian Pac J Allergy Immunol. 2017. PMID: 27001660 Free article.
Dengue vaccine: Global development update.
Prompetchara E, Ketloy C, Thomas SJ, Ruxrungtham K. Prompetchara E, et al. Among authors: ruxrungtham k. Asian Pac J Allergy Immunol. 2020 Sep;38(3):178-185. doi: 10.12932/AP-100518-0309. Asian Pac J Allergy Immunol. 2020. PMID: 30660171 Free article. Review.
Plant-Produced Receptor-Binding Domain of SARS-CoV-2 Elicits Potent Neutralizing Responses in Mice and Non-human Primates.
Siriwattananon K, Manopwisedjaroen S, Shanmugaraj B, Rattanapisit K, Phumiamorn S, Sapsutthipas S, Trisiriwanich S, Prompetchara E, Ketloy C, Buranapraditkun S, Wijagkanalan W, Tharakhet K, Kaewpang P, Leetanasaksakul K, Kemthong T, Suttisan N, Malaivijitnond S, Ruxrungtham K, Thitithanyanont A, Phoolcharoen W. Siriwattananon K, et al. Among authors: ruxrungtham k. Front Plant Sci. 2021 May 13;12:682953. doi: 10.3389/fpls.2021.682953. eCollection 2021. Front Plant Sci. 2021. PMID: 34054909 Free PMC article.
Optimization of a Der p 2-based prophylactic DNA vaccine against house dust mite allergy.
Pulsawat P, Pitakpolrat P, Prompetchara E, Kaewamatawong T, Techakriengkrai N, Sirivichayakul S, Buranapraditkun S, Hannaman D, Ruxrungtham K, Jacquet A. Pulsawat P, et al. Among authors: ruxrungtham k. Immunol Lett. 2013 Mar;151(1-2):23-30. doi: 10.1016/j.imlet.2013.01.013. Epub 2013 Feb 8. Immunol Lett. 2013. PMID: 23396105
389 results